About Peter Fong
Peter Fong is a director at Amani Therapeutics.
Experience
This experience comes from Peter Fong's profile and from SEC filings. For roles taken from filings, the years are when the filings name Peter Fong in the role, so the role may have started earlier or lasted longer.
Amani Therapeutics, Inc. Current
Chair of the Board of Directors
2026 – Present · New York, NY
Develops medicines for people with serious psychiatric disorders.
RP
Rocket Pharmaceuticals Current
Chair of the Board of Directors
2025 – Present
PB
Prolium Biosciences Current
Chair of the Board of Directors
2024 – Present
RL
RTW Investments, LP Current
Partner, President
2019 – Present
JP
Jixing Pharmaceuticals Current
Board Executive Director
2019 – Present
YB
Yarrow Bioscience
Chair of the Board of Directors
2025 – 2026
FP
Flagship Pioneering
Senior Principal
2018 – 2019
GE
Genentech
Associate Director, Oncology Business Development, Genentech Partnering
2016 – 2018
MC
Memorial Sloan-Kettering Cancer Center
New Ventures and Business Development
2009 – 2014
CT
Carigent Therapeutics
Co-Founder and VP of R&D
2007 – 2009
YU
Yale University
James Hudson Brown — Alexander Brown Coxe Postdoctoral Fellow
2003 – 2007
GE
GE
Chemist
1995 – 1998
Key Colleagues at Startups
The people Peter Fong works with at each company, as listed on that company's latest Form D.
Amani Therapeutics, Inc. · Form D, Oct 1, 2026
AL
Alice Lee
Executive officer
RL
-- RTW Holdings VI, LLC
Promoter
Robert Swoboda
Chief Operating Officer
LC
Lauren Cuje
Director
CW
Connor Williams
Director